N6-[(1S)-1-METHYL-2-PHENYLETHYL]-9H-(1-DEOXY-BETA-D-PSICOFURANOSYL)-ADENINE
Compound with spectra: 1 NMR
![N6-[(1S)-1-METHYL-2-PHENYLETHYL]-9H-(1-DEOXY-BETA-D-PSICOFURANOSYL)-ADENINE](/api/compound/GBvhfsqHOFF.png?ph=true&h=300&w=458 "N6-[(1S)-1-METHYL-2-PHENYLETHYL]-9H-(1-DEOXY-BETA-D-PSICOFURANOSYL)-ADENINE")
| SpectraBase Compound ID | GBvhfsqHOFF |
|---|---|
| InChI | InChI=1S/C20H25N5O4/c1-12(8-13-6-4-3-5-7-13)24-18-15-19(22-10-21-18)25(11-23-15)20(2)17(28)16(27)14(9-26)29-20/h3-7,10-12,14,16-17,26-28H,8-9H2,1-2H3,(H,21,22,24)/t12-,14-,16-,17-,20-/m0/s1 |
| InChIKey | LAUJHHDMVNOAOD-KEFZQLSMSA-N |
| Mol Weight | 399.45 g/mol |
| Molecular Formula | C20H25N5O4 |
| Exact Mass | 399.190654 g/mol |
| Enantiomer InChIKey | LAUJHHDMVNOAOD-CPJTVBMOSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
N6-CYCLOPENTYL-9H-(1-DEOXY-BETA-D-PSICOFURANOSYL)-ADENINE
9H-Purin-6-amine, 9-.beta.-D-psicofuranosyl-
OXETANE-C
9-(2,3,5-Tri-O-acetyl-.beta.,D-ribofuranosyl)-6-(1,2,4-triazol-4-yl)purine
(5R)-2-(acetoxymethyl)-5-(6-(furan-3-ylmethylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
9-(2-O-TETRAHYDROPYRANYL-BETA-L-RIBOFURANOSYL)-N(6)-BENZOYL-ADENOSINE;(DIASTEREOMER-1)
(2R,3R,4R,5R)-2-(6-((E)-4-acetoxy-3-methylbut-2-enylamino)-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl diacetate
(2R,3R,4R,5R)-2-(6-((Z)-4-acetoxy-3-methylbut-2-enylamino)-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl diacetate
[(2R,3R,4R,5R)-3,4-diacetoxy-5-[6-[[4,4,4-trideuterio-3-(trideuteriomethyl)but-2-enyl]amino]purin-9-yl]tetrahydrofuran-2-yl]methyl acetate
| Title | Journal or Book | Year |
|---|---|---|
| Ribose-Modified Nucleosides as Ligands for Adenosine Receptors: Synthesis, Conformational Analysis, and Biological Evaluation of 1‘-C-Methyl Adenosine Analogues | Journal of Medicinal Chemistry | 2002 |